Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GULDSMED GRAM ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6% 3.6%   Bankruptcy risk   4.5% 3.0% 2.6% 1.8% 2.6% 2.7% 9.4% 9.2%   Credit score (0-100)   48 59 61 71 61 59 26 27   Credit rating   BBB BBB BBB A BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,273 2,521 3,089 2,789 2,325 1,811 0.0 0.0   EBITDA   109 302 1,099 738 695 254 0.0 0.0   EBIT   -212 96.5 895 534 487 104 0.0 0.0   Pre-tax profit (PTP)   -478.7 -91.5 722.0 389.9 160.9 -248.6 0.0 0.0   Net earnings   -374.8 -74.5 562.2 301.4 109.2 -205.8 0.0 0.0   Pre-tax profit without non-rec. items   -479 -91.5 722 390 161 -249 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,028 865 661 457 310 159 0.0 0.0   Shareholders equity total   3,843 3,769 4,331 4,633 4,742 4,536 3,936 3,936   Interest-bearing liabilities   3,521 3,852 3,122 3,688 3,476 4,356 0.0 0.0   Balance sheet total (assets)   12,995 11,230 13,141 13,798 13,357 12,923 3,936 3,936   Net Debt   3,148 3,775 2,978 3,428 3,442 4,356 -3,936 -3,936     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,273 2,521 3,089 2,789 2,325 1,811 0.0 0.0   Gross profit growth   5.8% -23.0% 22.5% -9.7% -16.6% -22.1% -100.0% 0.0%   Employees   11 9 6 6 5 4 0 0   Employee growth %   22.2% -18.2% -33.3% 0.0% -16.7% -20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   12,995 11,230 13,141 13,798 13,357 12,923 3,936 3,936   Balance sheet change%   7.4% -13.6% 17.0% 5.0% -3.2% -3.3% -69.5% 0.0%   Added value   108.7 302.1 1,099.2 737.7 691.1 254.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -641 -369 -407 -407 -355 -301 -159 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -6.5% 3.8% 29.0% 19.1% 21.0% 5.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -1.4% 1.3% 7.9% 4.5% 4.3% 1.7% 0.0% 0.0%   ROI %   -2.5% 2.0% 12.4% 7.5% 6.8% 2.5% 0.0% 0.0%   ROE %   -9.3% -2.0% 13.9% 6.7% 2.3% -4.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   29.6% 33.6% 33.0% 33.6% 35.5% 35.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   2,896.8% 1,249.6% 271.0% 464.6% 495.0% 1,712.3% 0.0% 0.0%   Gearing %   91.6% 102.2% 72.1% 79.6% 73.3% 96.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.3% 6.6% 6.9% 6.4% 11.7% 12.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.3 0.3 0.3 0.2 0.3 0.0 0.0   Current Ratio   1.3 1.4 1.4 1.5 1.5 1.5 0.0 0.0   Cash and cash equivalent   372.7 77.3 143.3 260.7 34.8 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,646.6 2,772.1 3,599.2 4,114.9 4,256.4 4,161.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   10 34 183 123 138 64 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   10 34 183 123 139 64 0 0   EBIT / employee   -19 11 149 89 97 26 0 0   Net earnings / employee   -34 -8 94 50 22 -51 0 0